Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-16 | New | $250,000 | $250,000 | Equity Only | 06b | SEC link |
| 2024-06-07 | New | $125,000 | $125,000 | Other | 06b | SEC link |
| 2023-04-05 | Amended | $3,102,750 | $2,352,750 | Other | 06b | SEC link |
| 2022-05-03 | New | $750,000 | $750,000 | Other | 06b | SEC link |
| 2021-03-24 | New | $6,660,000 | $6,660,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Andrew Barlow | Director |
| Hogan Bassey | Director, Executive |
| Matt Elsberry | Director, Executive |
| Kevin Engel | Director, Executive |
| Wesley Lyons | Director |
| John Manwell | Director, Executive |
| Kris Maynard | Director |
| Michael Norman | Director, Executive |
| Yaw Nsarkoh | Director |
| Dave Rae | Director |
| Carl Thong | Director |
| Francis Yip | Director, Executive |